Wednesday, January 29, 2014

FDA’s first two warning letters since draft compounding guidances may be another way to encourage outsourcer registration.

Compounding Warning Letter Format Unchanged Since Legislation


Executive Summary

FDA’s first two warning letters since draft compounding guidances may be another way to encourage outsourcer registration.


Purchase this Article

$50.00   BUY NOW

For $50.00, purchase this 828-word articleand receive immediate online access. 100% Satisfaction Guarantee.

Already a Subscriber?

Log in for complete access.
LOG IN
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 748-1221.

No comments: